Leidos secures prime contract with ARPA-H to propel biomedical breakthroughs

Leidos (NYSE:LDOS), a renowned Fortune 500 innovation company, has recently been awarded a prime contract by the Advanced Research Projects Agency for Health (ARPA-H). This ... Read More